145 related articles for article (PubMed ID: 358766)
1. Lidocaine and the quarternary ammonium compound QX-572 in acute myocardial infarction. A comparative study.
Bergdahl B; Karlsson E; Magnusson JO; Sonnhag C
Acta Med Scand; 1978; 204(4):311-4. PubMed ID: 358766
[TBL] [Abstract][Full Text] [Related]
2. Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
Rydén L; Hjalmarson A; Wasir H; Werkö L
Br Heart J; 1974 Aug; 36(8):811-21. PubMed ID: 4413111
[No Abstract] [Full Text] [Related]
3. Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarction.
Rehnqvist N; Erhardt L; Ericsson CG; Olsson G; Svensson G; Sjögren A
Acta Med Scand; 1983; 214(1):21-7. PubMed ID: 6414252
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methyllidocaine and lidocaine on arrhythmias produced by coronary occlusion in the dog.
Gillis RA; Levine FH; Thibodeaux H; Raines A; Standaert FG
Circulation; 1973 Apr; 47(4):697-703. PubMed ID: 4696791
[No Abstract] [Full Text] [Related]
5. Prophylactic lidocaine in suspected acute myocardial infarction.
Goodman SL; Geiderman JM; Bernstein IJ
JACEP; 1979 Jun; 8(6):221-4. PubMed ID: 449144
[TBL] [Abstract][Full Text] [Related]
6. Effects of the quaternary ammonium compound OX-572 on ventricular tachyarrhythmias complicating acute myocardial infarction.
Rydén L; Hjalmarson A; Waldenström A
Br Heart J; 1975 Apr; 37(4):426-37. PubMed ID: 1125119
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
Rydén L; Hjalmarson A ; Kvasnicka J; Liander B
Br Heart J; 1975 Jan; 37(1):65-73. PubMed ID: 1089426
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction.
Touboul P; Moleur P; Mathieu MP; Vrancea F; Ferry S; Kirkorian G; Atallah G; Marchand A; Stahl C; Zoheir F
Eur Heart J; 1988 Nov; 9(11):1188-93. PubMed ID: 3234410
[TBL] [Abstract][Full Text] [Related]
9. The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction.
Chung EK
Singapore Med J; 1973 Sep; 14(3):205-10. PubMed ID: 4591400
[No Abstract] [Full Text] [Related]
10. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery.
Morganroth J; Panidis IP; Harley S; Johnson J; Smith E; MacVaugh H
Am J Cardiol; 1984 Dec; 54(10):1253-8. PubMed ID: 6439023
[TBL] [Abstract][Full Text] [Related]
11. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
Krejcy K; Krumpl G; Todt H; Raberger G
Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):213-8. PubMed ID: 1448183
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
[TBL] [Abstract][Full Text] [Related]
13. Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction.
Rehnqvist N; Ericsson CG; Eriksson S; Olsson G; Svensson G
Acta Med Scand; 1984; 216(5):525-30. PubMed ID: 6395642
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
Fredrick DS; Boersma RB
Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction.
Wyse DG; Kellen J; Rademaker AW
J Am Coll Cardiol; 1988 Aug; 12(2):507-13. PubMed ID: 3292630
[TBL] [Abstract][Full Text] [Related]
16. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
Leinonen H; Heikkilä J; Sundberg S; Gordin A
Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antiarrhythmic drug therapy in acute myocardial infarction.
Binnion PF; Das Gupta R
Cardiovasc Clin; 1975; 7(2):203-17. PubMed ID: 145
[No Abstract] [Full Text] [Related]
18. Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound QX-572 in man.
Rydén L; Berlin A; Treiber LR
Eur J Clin Pharmacol; 1975 Apr; 8(3-4):277-82. PubMed ID: 1233225
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of aprindine (AC 1802) and lidocaine by intravenous route during the acute phase of myocardial infarct].
Depaepe A; Bohyn P; De Maertelaere M; Dernier J; Cloetens W; De Mey D
Acta Cardiol; 1974; Suppl 18():423-32. PubMed ID: 4138738
[No Abstract] [Full Text] [Related]
20. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML
Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
